Expertise: Oncology & Hematology 104 results

Oncology & Hematology

Operationalizing AI and RWE in Oncology: Converging Regulatory Landscapes

Artificial intelligence (AI) and real-world evidence (RWE) are playing a growing role across oncology development—from patient stratification and trial design to post-approval monitoring. As adoption accelerates, regulators are setting clearer expectations to ensure these tools are applied with transparency, rigor, and accountability. ...

Oncology & Hematology

Operationalizing ADC Clinical Trials: Dose, Safety, and Design

Antibody–drug conjugates (ADCs) are rapidly reshaping the oncology treatment landscape. By combining the targeting precision of monoclonal antibodies with the cytotoxic potency of small-molecule payloads, ADCs offer the promise of improved efficacy with more controlled toxicity. This potential has fueled...

Oncology & Hematology

AI and RWE: Powering the Future of Oncology

As the pace of innovation in oncology accelerates, artificial intelligence (AI) and real-world evidence (RWE) are reshaping how researchers understand disease, design studies, and deliver care. These technologies are bridging science, data, and clinical insight in ways that were once...